Skip to main content

Table 3 TNM Staging. Group I, patients who were diagnosed histologically; Group II, patients who were diagnosed radiologically

From: Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data

TNM stage*

Group I (n = 2920)

Group II (n = 5562)

Stage I (n, %)

329(11.3)

1,065(19.1)

Stage II (n, %)

1,512(51.8)

1,875(33.7)

Stage III (n, %)

438(15.0)

1,507(27.1)

Stage IV-A (n, %)

60(2.1)

631(11.3)

Stage IV-B (n, %)

50(1.7)

456(8.2)

Undefined (n, %)

531(18.2)

28(0.5)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us